Daniel D. De Carvalho
Molecular Biology · 2010–2014
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 66 citations into it; #15,198 of 17,773 by trust here, #12,227 by citations
- Cancer Research — 12 citations into it
Whom Daniel D. De Carvalho trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Daniel D. De Carvalho overall
Papers from Daniel D. De Carvalho's perspective
Ordered by how strongly the researchers Daniel D. De Carvalho trusts endorse each paper. Same corpus, a different order for every researcher.
- Human DNA methylomes at base resolution show widespread epigenomic differences
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 (Science)
- Epigenetics in cancer. (Carcinogenesis)
- The epigenomics of cancer. (Cell)
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation (Nature Genetics)
- A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing (Nature Genetics)
- Hallmarks of cancer: the next generation. (Cell)
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer (Science)
- MicroRNA signatures in human cancers (Nature Reviews. Cancer)
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. (Cancer Cell)
Their papers
- Epigenetic Modifications as Therapeutic Targets (2010) — 808 citations
- Gene Body Methylation can alter Gene Expression and is a Therapeutic Target in Cancer (2014) — 1,074 citations